Can tramadol, cefixime, and paracetamol (acetaminophen) cause pancreatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tramadol, Cefixime, and Paracetamol as Potential Causes of Pancreatitis

Tramadol, cefixime, and paracetamol are not commonly associated with pancreatitis, though GLP-1 receptor agonists like liraglutide and semaglutide have been reported to cause pancreatitis in clinical trials. 1

Medication-Specific Risk Assessment

Tramadol

  • Not classified as a high-risk medication for pancreatitis
  • No strong evidence linking tramadol to pancreatitis in current guidelines
  • Studies examining tramadol in patients with chronic pancreatitis focus on its use as a treatment rather than a cause 2, 3
  • Tramadol has been shown to be an effective analgesic for pancreatitis pain with fewer gastrointestinal side effects compared to morphine 3

Cefixime

  • Not listed among antibiotics associated with pancreatitis in major guidelines
  • Antibiotics as a class are rarely implicated in pancreatitis
  • Cefixime specifically is not mentioned in drug-induced pancreatitis classifications 4, 5

Paracetamol (Acetaminophen)

  • Classified as a Class II medication for pancreatitis risk (implicated in more than 10 cases) 5
  • However, this represents a very small percentage given its widespread use
  • Studies on paracetamol in pancreatitis patients focus on its use as treatment rather than cause 6

Drug-Induced Pancreatitis: General Considerations

Epidemiology

  • Drug-induced pancreatitis accounts for only 0.1-2% of all acute pancreatitis cases 4
  • Diagnosis requires exclusion of common causes (gallstones, alcohol)
  • Most cases are mild, but severe and fatal cases can occur 4

Higher Risk Populations

Certain groups have increased susceptibility to drug-induced pancreatitis:

  • Elderly patients on multiple medications
  • HIV-positive patients
  • Cancer patients
  • Patients on immunomodulating agents 5

Medications with Stronger Evidence

Medications with stronger evidence for causing pancreatitis (not including those in the question):

  • Class I (>20 reported cases with rechallenge): didanosine, azathioprine, valproic acid, estrogens, opiates, tetracycline, steroids, furosemide 5
  • GLP-1 receptor agonists: liraglutide and semaglutide have been reported to cause pancreatitis in clinical trials 1

Clinical Approach to Suspected Drug-Induced Pancreatitis

Diagnostic Algorithm

  1. Confirm pancreatitis diagnosis (elevated lipase/amylase, compatible imaging)
  2. Rule out common causes (gallstones, alcohol, hypertriglyceridemia)
  3. Review medication history for high-risk drugs
  4. Consider temporal relationship between drug initiation and symptom onset
  5. Assess for improvement after drug discontinuation

Management

If drug-induced pancreatitis is suspected:

  • Discontinue the suspected medication immediately
  • Provide supportive care as per acute pancreatitis guidelines 1, 7
  • Avoid rechallenge with the suspected medication
  • Consider alternative medications with lower pancreatitis risk

Conclusion

While tramadol, cefixime, and paracetamol are not commonly associated with pancreatitis, any medication can potentially cause idiosyncratic reactions. Paracetamol has been classified as a Class II medication for pancreatitis risk, but the absolute risk remains very low. The diagnosis of drug-induced pancreatitis should be considered when other common causes have been excluded and there is a clear temporal relationship between drug administration and symptom onset.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ketoprofen and tramadol pharmacokinetics in patients with chronic pancreatitis.

European review for medical and pharmacological sciences, 2019

Research

Drug-induced pancreatitis: an update.

Journal of clinical gastroenterology, 2005

Guideline

Acute Pancreatitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.